Sarepta Therapeutics
- Market cap
- 1.85B
- P/E (TTM)i
- -11.15
- P/Bi
- 1.21
- EPSi
- -7.13
- Div yieldi
- 0.00%
- 52W posi
- 28%
Anonymous reader poll. Unscientific, not investment advice.
Sarepta Therapeutics shares were changing hands at 17.50, up 1.10% on the day. Its market capitalisation is about 1.85B, the #2853 most valuable US-listed company we track. The trailing P/E of -11.03 is 147% below its five-year average of 23.56. The 16 analysts covering the stock are, on balance, at Hold, targeting an average of 22.43 (+28%). The shares sit 28% of the way up their 52-week range of 14.68 to 24.68.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average and near the bottom of the universe on momentum.
- Signal has read STRONG SELL for 1 day.
- Its last 4 Sell calls were followed by roughly flat moves (-1%) three months out.
- Recent price momentum is -17.9% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 24.1% of float.
- Analyst tilt is Hold.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 17.31
- Open
- 17.28
- Day range
- 16.98 - 17.67
- Avg price
- 17.49
- Volume
- 2.87M
- Turnover
- 50.24M
- Turnover ratei
- 2.86%
- Volume ratioi
- 1.16
- Amplitudei
- 3.96%
- 52-week rangei
- 14.68 - 24.68
Valuation
- P/Ei
- -2.45
- P/E (TTM)i
- -11.15
- P/Bi
- 1.21
- EPSi
- -7.13
- Book value / shi
- 14.46
- Net profit
- -753.12M
- Net assets
- 1.53B
Share structure
- Market cap
- 1.85B
- Float capi
- 1.76B
- Shares out
- 105.63M
- Float sharesi
- 100.54M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
29.1% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+11.49M net over the window
Short interest
- Shares short
- 25.43M
- % of floati
- 24.08%
- Days to coveri
- 8.02
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Sarepta Therapeutics (SRPT)?
Sarepta Therapeutics last traded at 17.50. The quote on this page refreshes every few seconds while US markets are open.
What is Sarepta Therapeutics's market cap?
About 1.85B.
What is the P/E ratio of Sarepta Therapeutics?
The trailing twelve-month P/E is -11.15, below its own 5-year average of 23.56 — in the middle of its historical range (52.31% percentile). See the Valuation tab for the full history.
Does Sarepta Therapeutics pay a dividend?
Sarepta Therapeutics does not currently pay a regular dividend.
Is Sarepta Therapeutics a buy according to analysts?
The consensus of 16 analysts is a Hold rating, with an average 12-month price target of 22.43, which implies 28.2% upside from the current price. This is not investment advice.
What is Sarepta Therapeutics's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Sarepta Therapeutics a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.
Quote time 2026-10-08 04:00:03 · For reference only, not investment advice and not tailored to your situation.